Irish MPS Society pledges to work hard to reverse the HSE decision on Vimizim


Irish MPS Society Logo

Irish MPS Society pledges to work hard to reverse the HSE decision on Vimizim

The Irish MPS Society has expressed its disappointment in the HSE’s decision to deny access to Vimizim in Ireland. Read their full press release below. HSE Refuse Funding The HSE have confirmed that they WILL NOT FUND the life changing drug VIMIZIM for those

Eurordis logo

Members needed for focus group on rare disease app

We have received a request from Eurordis (the European Rare Disease Organisation) to see if we could find 3–4 adults who are patients with Fabry, an MPS or related lysosomal storage disease to be part of an important Focus Group

MPS Society logo

HSE refuses funding for Vimizim

A letter published on the Irish MPS Society website on 20 July confirms that the HSE has decided to refuse funding for Vimizim in Ireland. The letter states that “due to lack of clinical data and a perceived lack of

MPS Society logo

Alexion MPSIIIB clinical trial update

Monday 17 July 2017 Alexion MPSIIIB Enzyme Replacement Clinical Trial Dr Suresh Vijay, Clinical Trial Principal Investigator at Birmingham Children’s Hospital has confirmed that it is business as usual until he gets clarification from Alexion on the status of the

MPS Society logo

Clinical trials for MPSIIIB stopped

14 July 2017 The MPS Society has just been informed by the PI Dr Suresh Vijay from Birmingham Children’s Hospital that the NGLU clinical trials for MPSIIIB have been stopped with immediate effect. At this time neither the CRO, PPD,